Today on DrugResearcher.com   BMS buys biologics partner, strengthens oncology Innovation 'key' to India's pharma future New UK joint venture bets on membrane biology services ProImmune launches T cell antigen prediction assay Merck's HIV vaccine steps out of development

Related Industry News   Ventana continues to brush off Roche's advances US firm launches online patient recruitment tool Indian manufacturers need to lose generic mindset Gardasil beware, Cervarix hot on your heels

Breaking News on Drug Discovery
Daily  Tuesday 25 September 2007		Forward to a colleague

	Company Profile CHIRALPAK® IC CHIRAL TECHNOLOGIES EUROPE announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA , IB and now IC provides a screening set of columns with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just 3 columns and four mobile phase combinations... Click Here Access Full Stories BMS buys biologics partner, strengthens oncology Bristol-Myers Squibb (BMS) will pay up to $490m (€348m) for Adnexus Therapeutics, as it continues its transformation into a biopharmaceutical company and strengthens its oncology pipeline... Read Innovation 'key' to India's pharma future The key to the future of India's pharmaceutical industry will depend on its ability to scale back its over-reliance on low-cost manufacturing and to foster innovation, with drug discovery and biosimilars presenting... Read New UK joint venture bets on membrane biology services A UK university and a British consultancy firm have teamed up to offer outsourced R&D services focused on membrane biology - an increasingly promising area of drug development... Read ProImmune launches T cell antigen prediction assay ProImmune has launched a new cell-free assay for Class II HLA (human leukocyte antigen) that can help understand key helper T cell immune responses and aid the design of highly targeted therapies... Read Merck's HIV vaccine steps out of development Merck & Co. has stopped the Phase II trial of its V520 HIV vaccine after interim results showed that the vaccine was not effective and did not prevent infection... Read
	All News Headlines for: September | August | July
	Technical / White Paper DeltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
	Related Industry News Ventana continues to brush off Roche's advances Roche's latest takeover bid extension has been brushed off by histopathology diagnostics expert Ventana as it believes 'it is worth significantly more' than the current $3bn (€2.1bn) offer... Read US firm launches online patient recruitment tool Californian marketing company BlueLithium has launched a new web-based solution to help pharma companies overcome the challenges of recruiting patients for clinical trials... Read Indian manufacturers need to lose generic mindset Indian drug manufacturers need to rid themselves of their generic mindset in order to evolve and remain competitive for the future... Read Gardasil beware, Cervarix hot on your heels GlaxoSmithKline (GSK) has been granted EU approval of its adjuvanted cervical cancer vaccine Cervarix, and is confident that the jab can challenge the likes of Merck's high-profile Gardasil... Read Inside India: special series Innovation 'key' to India's pharma future The key to the future of India's pharmaceutical industry will depend on its ability to scale back its over-reliance on low-cost manufacturing and to foster innovation, with drug discovery and biosimilars presenting particular opportunities. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Pfizer to spin off Japan drug research lab Pfizer is considering offers from investors in a bid to spin off its drug research and development laboratory in Japan and make it an independent entity, according to media reports... Read Sanofi imaging cancer drug 'sensors' Sanofi-Aventis is using the latest targeted imaging techniques to assess how its cancer drugs affect organisms at the molecular level... Read New US player in contract assay services field The burgeoning US contract assay services arena has witnessed the arrival of a brand new player with the launch of ReachBio, which is opening its business operations this week... Read 3D scaffold elevates drug screening results UK researchers have developed a plastic cell scaffold that enables cells to be grown in realistic 3D  structures and promises to enable better cell based drug screening results... Read Drugs moving into the clinic: 28 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com